Keith R. Leonard, Jr.
Unity Biotechnology, Inc., Chief Executive Officer, Board Member
Keith R. Leonard, Jr. has been a member of our Board of Directors since January 2016. He has more than 20 years of experience in the pharmaceutical industry and is currently the Chief Executive Officer and member of the board of directors of Unity Biotechnology, Inc. since January 2016. Leonard served as President, Chief Executive Officer and member of the board of directors of Kythera Biopharmaceuticals, Inc., a biopharmaceutical company that he co-founded, which focused on discovering, developing, and commercializing drugs for the aesthetic medicine market, from 2005 until its acquisition by Allergan plc in October 2015. From 1991 to 2004, Leonard held various positions at Amgen Inc., most recently as Senior Vice President and General Manager of Amgen Europe where he was responsible for all commercial operations in 28 European countries.
Leonard served on the Board of Directors of Anacor Pharmaceuticals, Inc. from June 2014 to June 2016. He also serves on the Board of Directors of several private companies.
Mr. Leonard received a B.S. in Engineering from the University of California, Los Angeles and a B.A. in History from the University of Maryland. He also holds an M.S. in Engineering from the University of California, Berkeley and an M.B.A. from the Anderson School of Management, University of California, Los Angeles.
Leonard served on the Board of Directors of Anacor Pharmaceuticals, Inc. from June 2014 to June 2016. He also serves on the Board of Directors of several private companies.
Mr. Leonard received a B.S. in Engineering from the University of California, Los Angeles and a B.A. in History from the University of Maryland. He also holds an M.S. in Engineering from the University of California, Berkeley and an M.B.A. from the Anderson School of Management, University of California, Los Angeles.